ADD:
A medical institution has treated 4,000 patients with ADHD of the hyperactive form, while 3,000 patients were treated for the inattentive or quiet form of ADHD. The focus should be on the brain physiology that causes ADD symptoms rather than labels such as ADHD. The ADD label is confusing and harmful to patients. According to their clinical research, ADD patients are intelligent but struggle to focus their minds well enough to use their high IQ.

For ADD patients to benefit from dopamine-enhancing medication, they need to have their overactive brain regions properly diagnosed. Treatment must be approached in a sophisticated and balanced way. If dopamine activity is increased in an imbalanced way, patients may become more irritable and depressed, leading them to avoid medication that could transform their lives.

Effective ADD treatment requires knowledge of brain physiology, the interconnectivity of different brain regions, and the ability to balance the electrical activity of six different brain regions. To start healing from ADD, patients should complete a form or call the Grossgold Clinic in Clearwater, FL.

ADD symptoms stem from an underactive prefrontal cortex, which is responsible for executive functions such as top-down management, impulse control, and filtering stimuli. Patients with an underactive prefrontal cortex struggle to prioritize tasks and tend to procrastinate. They also experience brain fog in the morning, which they may self-medicate with nicotine and coffee.

Most ADD patients inherit an underactive prefrontal cortex from one of their parents, while others develop it due to brain trauma or neurotoxicity. However, most ADD patients also have overactive brain regions, which they develop due to changes in the environment and excessive antibiotics in their food supply.

ADD patients have different personalities, so they require individualized treatment. The medical institution has correlated different personality profiles of ADD patients with their brain scans and brain chemistry patterns. ADD patients who inherit a super COMT enzyme have a genetic cause of their condition. The COMT enzyme metabolizes dopamine in the synapse, and those with a super COMT enzyme break down dopamine faster, leading to less dopamine in the prefrontal cortex, which has fewer dopamine recycle wagons than other brain regions.